Big Move For Proteon Therapeutics, Inc.
Mon 13 Jan 20 at 05:30 PM
Proteon Therapeutics, Inc. (PRTO:NASDAQ) rocketted at $0.84, representing a gain of 30.5%. The stock got featured on our News Catalysts scanner on Thu 09 Jan 20 at 07:00 PM in the 'MERGER' category. From Thu 19 Dec 19, the stock recorded 71.43% Up Days and 66.67% Green Days
About Proteon Therapeutics, Inc. (PRTO:NASDAQ)
Proteon Therapeutics Inc is an late-stage biopharmaceutical company engaged in the development of novel pharmaceuticals to address the needs of patients with renal and vascular disease.
Top 10 Gainers:
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 200%
- Dare Bioscience, Inc. (DARE:NASDAQ), 97.6%
- NantKwest, Inc. (NK:NASDAQ), 91.01%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 50.4%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 46.15%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- iFresh Inc. (IFMK:NASDAQ), 29.67%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 28.77%
- Primo Water Corporation (PRMW:NASDAQ), 25.43%
- Cardlytics, Inc. (CDLX:NASDAQ), 24.65%